menu
    • menu

    Company profile for NAYA Therapeutics

    NEW Drugs in Dev: 3
    AbbVie CDMO has been working with global companies to develop, manufacture & scale biopharmaceutical products.

    Virtual Booth

    Contact Supplier

    Munit offers scalable GMP micronization and particle size engineering to enhance drug solubility, bioavailability, and performance.

    Virtual Booth

    Contact Supplier

    pharmacompass-1-m-2026-04-20

    Virtual Booth

    Contact Supplier

    PMC Isochem is your partner for smart CDMOs of Intermediates, APIs, & excipients & a catalog of Intermediates & Generic APIs.

    Virtual Booth

    Contact Supplier

    Expand your portfolio with Egis- value-added generics, API capabilities, and reliable contract services to drive your growth.

    Virtual Booth

    Contact Supplier

    pharmacompass-2-m-2026-04-20

    Virtual Booth

    Contact Supplier

    EVENTS

    DIGITAL CONTENT

    DEVELOPMENTS

    PharmaCompass

    Only Regulatory Products (API/FDF), Drugs in Developments and News are Updated on this Virtual Booth

    Update your Virtual Booth on PharmaCompass, ask us

    About

    NAYA Therapeutics is a clinical-stage biopharmaceutical company pioneering next-generation bifunctional antibodies to transform oncology care. Our proprietary plug-and-play antibody platform enhances avidity and creates a targeted synapse effect for precise tumor elimination. Focused on HCC and Multiple Myeloma, our lead asset, NY-303 (GPC3×NKp46), targets immunotherapy-resistant HCC patients (70-85% of treatable cases), with...
    NAYA Therapeutics is a clinical-stage biopharmaceutical company pioneering next-generation bifunctional antibodies to transform oncology care. Our proprietary plug-and-play antibody platform enhances avidity and creates a targeted synapse effect for precise tumor elimination. Focused on HCC and Multiple Myeloma, our lead asset, NY-303 (GPC3×NKp46), targets immunotherapy-resistant HCC patients (70-85% of treatable cases), with Phase I/IIa trials initiating H2 2025. We are expanding a pipeline of highly differentiated therapies to address unmet needs in solid and hematologic malignancies.

    List your booth number for exhibitions, ask us

    CONTACT DETAILS

    Click the arrow to open the dropdown
    Contact SupplierContact
    Google MapGoogle Map
    Full View ScreenFull View Screen
    NAYA TherapeuticsUnited_States_of_America Flag
    Country
    Country
    U.S.A
    Address
    Address
    1200 Brickell Avenue, Suite 1960 Miami, FL, 33131
    Telephone
    Telephone
    Client Email
    Email
    enquiries@pharmacompass.com
    Client Website
    Website
    https://www.nayatx.com/
    Linkedin
    Linkedin
    youtube
    YouTube
    Twitter
    Twitter

    Upload your Marketing & Sales content on your company Virtual Booth, click HERE.

    Events

    Webinars & Exhibitions

    Request a meetingRequest a meeting
    Full Screen ViewFull Screen View
    AMWC Asia-TDAC

    AMWC Asia-TDAC

    Not Confirmed

    envelop Contact Supplier

    AMWC Asia-TDAC

    Post an Enquiry

    Meeting

    Digital content

    Create Content with PharmaCompass, ask us

    NEWS #PharmaBuzz

    read-more
    read-more
    NAYA Therapeutics Announces World-Class Board Of Directors
    NAYA Therapeutics Announces World-Class Board Of Directors

    17 Mar 2026

    // ACCESSWIRE

    https://www.accessnewswire.com/newsroom/en/biotechnology/naya-therapeutics-announces-world-class-board-of-directors-1148490

    ACCESSWIRE
    17 Mar 2026
    Share Share
    NAYA Therapeutics Names Jason D. Hurt as Chief Medical Officer
    NAYA Therapeutics Names Jason D. Hurt as Chief Medical Officer

    17 Feb 2026

    // PHARMIWEB

    https://www.pharmiweb.com/press-release/2026-02-17/naya-therapeutics-appoints-jason-d-hurt-md-mba-as-chief-medical-officer

    PHARMIWEB
    17 Feb 2026
    Share Share
    NAYA Therapeutics Opens Hub at Paris-Saclay Cancer Institute
    NAYA Therapeutics Opens Hub at Paris-Saclay Cancer Institute

    07 Jan 2026

    // PHARMIWEB

    https://www.pharmiweb.com/press-release/2026-01-07/naya-therapeutics-announces-european-research-manufacturing-hub-at-paris-saclay-cancer-cluster-ps

    PHARMIWEB
    07 Jan 2026
    Share Share
    NAYA Therapeutics To Present At NOAR Europe Annual Meeting
    NAYA Therapeutics To Present At NOAR Europe Annual Meeting

    04 Nov 2025

    // PHARMIWEB

    https://www.pharmiweb.com/press-release/2025-11-04/naya-therapeutics-to-present-at-the-network-for-optimized-astatine-labeled-radiopharmaceuticals-noa

    PHARMIWEB
    04 Nov 2025
    Share Share
    NAYA Partners Alpha Nuclide For Gpc3 Astatine-211 Therapy
    NAYA Partners Alpha Nuclide For Gpc3 Astatine-211 Therapy

    13 Oct 2025

    // ACCESSWIRE

    https://www.accessnewswire.com/newsroom/en/biotechnology/naya-announces-partnership-with-alpha-nuclide-to-support-clinical-development-in-chin-1086081

    ACCESSWIRE
    13 Oct 2025
    Share Share
    Naya Therapeutics Partners Atley Solutions for Astatine-211
    Naya Therapeutics Partners Atley Solutions for Astatine-211

    02 Sep 2025

    // PHARMAWEB

    https://www.pharmiweb.com/press-release/2025-09-02/naya-therapeutics-to-partner-with-atley-solutions-to-accelerate-development-commercialization-of-i

    PHARMAWEB
    02 Sep 2025
    Share Share

    ABOUT THIS PAGE

    Ask Us for Pharmaceutical Supplier and Partner
    Ask Us, Find A Supplier / Partner
    No Commissions, No Strings Attached, Get Connected for FREE

    What are you looking for?

    How can we help you?

    The request can't be empty

    Please read our Privacy Policy carefully

    You must agree to the privacy policy

    The name can't be empty
    The company can't be empty.
    The email can't be empty Please enter a valid email.
    The mobile can't be empty
    • Privacy policy
    • Terms and conditions
    • Disclaimers
    • LinkedIn
    • Product listings are provided for informational purposes only. We do not supply or sell any products. Any products that may be covered by patent(s) are supplied solely for uses permitted under Section 107A of the Indian Patents Act and not for commercial sale.

    Market Place

    Market Place

    PharmaCompass

    Home

    Market Place

    Menu

    Post Enquiry

    Post Enquiry

    Market Place

    Market Place

    Search